A subsequent study looking at the re-activation and relative CTL activity of in vivo primed splenocytes found that anti-MIF specifically increases CTL activity against the same irradiated syngeneic tumor cell line in vitro while control mAb and rMIF had no effect (141). The gene discussed is MIF; the disease is neoplasm.